4 completed, 1 enrolling by invitation, 1 recruiting. 5 Not applicable, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 3, Enrolling by invitation 1, Recruiting 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow Michele Staton: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Kentucky Women's Justice Community Overdose Innovation Network - Phase II Overdose Prevention Intervention Package (OPIP) - Overdose Risk, Opioid Use Disorder | Not applicable | Recruiting | Michele Staton | 300 | 2026-06-23 | 2026-09-16 |
| Trauma-informed Intervention to Reduce Substance Use and to Support Community Transition TAU + TRUST, TAU + TRUST + Re-entry Recovery Support, Treatment as Usual (TAU) - Substance Use Disorder (SUD) | Not applicable | Enrolling by invitation | Michele Staton | 264 | 2025-12-09 | 2026-06-09 |
| Kentucky Women's Justice Community Opioid Innovation Network MOUD Pre-Treatment Telehealth, MOUD Pre-Treatment Telehealth and Peer Navigator, Services as Usual - Opioid-use Disorder | Not applicable | Completed | Michele Staton | 900 | 2020-12-17 | 2026-05-18 |
| Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder XR-NTX community location - Opioid Dependence | Early Phase 1 | Completed | Michele Staton | 9 | 2019-09-11 | 2023-03-27 |
| Social Media HIV Prevention Intervention for High Risk Rural Women NIDA Standard for HIV Prevention - HIV/AIDS | Not applicable | Completed | Michele Staton | 60 | 2019-05-29 | 2026-06-15 |
| Brief Intervention for Rural Women at High Risk for HIV/HCV MI-based HIV Risk Reduction - Acquired Immune Deficiency Syndrome Virus, Hepatitis C | Not applicable | Completed | Michele Staton | 400 | 2012-12-01 | 2019-10-08 |
Opioid-Related Disorders (3) · Acquired Immunodeficiency Syndrome (2) · Drug Overdose (2) · Substance-Related Disorders (2) · Hepatitis C (1)
Motivational Interviewing (1) · Therapeutics (1) · vivitrol (1)
United States (6)
Kevin Knight, PhD (1) · Michele Tindall, PhD (1)
PMID 39367439, PMID 42010616, PMID 42568290
1UG1DA050069 (1), R01DA033866 (1), R33DA061365 (1), R34DA045563 (1), R34DA045856 (1), RM1DA064496 (1)